Filter
294
Text search:
inflammation
Featured
Recommendations
45
New Publications
66
Language
Document type
No document type
141
Guidelines
57
Studies & Reports
48
Manuals
18
Training Material
10
Fact sheets
10
Strategic & Response Plan
4
Brochures
3
Infographics
2
Resource Platforms
1
Countries / Regions
India
19
Global
18
Kenya
11
South Africa
11
Ethiopia
8
Africa
7
Nigeria
6
Western and Central Europe
6
Philippines
5
Germany
5
Uganda
4
Latin America and the Carribbean
4
Senegal
3
Congo, Democratic Republic of
3
Rwanda
3
Malawi
3
Namibia
3
Brazil
3
Guinea
2
Burkina Faso
2
Sierra Leone
2
Liberia
2
Nepal
2
Zambia
2
Tanzania
2
Cambodia
2
Bangladesh
2
Eswatini/ Swaziland
2
Lesotho
2
Myanmar / Burma
2
East and Southern Africa
2
West and Central Africa
2
Asia
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Cameroon
1
Ghana
1
Zimbabwe
1
Haiti
1
South Sudan
1
Iraq
1
Syria
1
China
1
Indonesia
1
Papua New Guinea
1
Sudan
1
Benin
1
North Macedonia
1
Ukraine
1
Botswana
1
Middle East and North Africa
1
South–East Asia Region
1
Venezuela
1
Eastern Europe
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
101
Clinical Guidelines
54
Public Health
27
Women & Child Health
17
Key Resources
8
Capacity Building
6
Pharmacy & Technologies
2
Toolboxes
NTDs
32
NCDs
24
HIV
21
TB
16
COVID-19
16
Caregiver
12
Mental Health
11
AMR
11
Refugee
9
Disability
8
Planetary Health
8
Rapid Response
6
Pharmacy
5
Ebola & Marburg
4
Specific Hazards
3
Conflict
2
Zika
2
Natural Hazards
1
Global Health Education
1
Malaria
1
2.0 Rapid Response
1
This booklet is recommended for all health workers who diagnose and treat leprosy, especially those at the first referral level such as a health centre. It contains more detail than the WHO Guide to Eliminate Leprosy as a Public Health Problem. The Guide gives practical advice on how to diagnose lep
...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their
...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t
...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel
...
Trachoma is an eye infection that for thousands of years caused many people to go blind across all continents. As the result of development and targeted interventions, trachoma is now limited to an estimated 57 countries, often affecting the poorest
populations of the world. Today, more than 2 mill
...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid
...
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde
...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
